1. 2022-RA-605-ESGO Long term quality of life after chemotherapy among rare ovarian cancer survivors: the national gineco case-control Vivrovaire Rare Tumors study. (20th October 2022) Authors: Joly, Florence; Ray-Coquard, Isabelle Laure; Floquet, Anne; Lefèvre-Arbogast, Sophie; Selle, Frederic; Berton, Dominique; Frank, Sophie; Rouge, Thibault De La Motte; Kalbacher, Elsa; Provansal, Magali; Lortholary, Alain; Orfeuvre, Hubert; Alexandre, Jerome; Augereau, Paule; Nadeau, Cédric; Kurtz,... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101). (10th December 2020) Authors: Berton-Rigaud, Dominique; Vergote, Ignace; Pautier, Patricia; Kryzhanivska, Anna; Angelergues, Antoine; Kornacki, Deanna; Dudzisz-Sledz, Monika; Tian, Chuan; Bourayou, Nawel; Selle, Frederic Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 268 A phase 1 study of retifanlimab (INCMGA00012), a PD-1 inhibitor, in patients with advanced solid tumors: preliminary results in recurrent MSI-high or dMMR endometrial cancer (POD1UM-101). (9th November 2020) Authors: Berton-Rigaud, Dominique; Vergote, Ignace; Pautier, Patricia; Kryzhanivska, Anna; Angelergues, Antoine; Kornacki, Deanna; Dudzisz-Sledz, Monika; Tian, Chuan; Bourayou, Nawel; Selle, Frederic Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A294 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial. Issue 4 (14th December 2020) Authors: Gonzalez Martin, Antonio; Sanchez Lorenzo, Luisa; Colombo, Nicoletta; dePont Christensen, René; Heitz, Florian; Meirovitz, Mihai; Selle, Frederic; van Gorp, Toon; Alvarez, Nuria; Sanchez, Javier; Marqués, Carmen Journal: International journal of gynecological cancer Issue: Volume 31:Issue 4(2021) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT‐Ov41/GEICO 69‐O/ANITA Trial. Issue 4 (April 2021) Authors: Martin, Antonio Gonzalez; Lorenzo, Luisa Sanchez; Colombo, Nicoletta; dePont Christensen, René; Heitz, Florian; Meirovitz, Mihai; Selle, Frederic; van Gorp, Toon; Alvarez, Nuria; Sanchez, Javier; Marqués, Carmen Journal: International journal of gynecological cancer Issue: Volume 31:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial. Issue 4 (14th December 2020) Authors: Gonzalez Martin, Antonio; Sanchez Lorenzo, Luisa; Colombo, Nicoletta; dePont Christensen, René; Heitz, Florian; Meirovitz, Mihai; Selle, Frederic; van Gorp, Toon; Alvarez, Nuria; Sanchez, Javier; Marqués, Carmen Journal: International journal of gynecological cancer Issue: Volume 31:Issue 4(2021) Page Start: 617 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Mullerian Adenosarcoma of the Female Genital Tract. (1st November 2014) Authors: Friedlander, Michael Leonard; Covens, Alan; Glasspool, Rosalind M.; Hilpert, Felix; Kristensen, Gunnar; Kwon, Sanghoon; Selle, Frederic; Small, William; Witteveen, Els; Russell, Peter Journal: International journal of gynecological cancer Issue: Volume 24(2014)Supplement 3 Page Start: S78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer. Issue 4 (April 2022) Authors: Harter, Philipp; Sehouli, Jalid; Vergote, Ignace; Ferron, Gwenael; Reuss, Alexander; Meier, Werner; Greggi, Stefano; Mosgard, Berit J.; Selle, Frederic; Guyon, Frederic; Pomel, Christophe; Lécuru, Fabrice; Zang, Rongyu; Avall-Lundqvist, Elisabeth; Kim, Jae‐Weon; Ponce, Jordi; Raspagliesi, Frances... Journal: Obstetrical & gynecological survey Issue: Volume 77:Issue 4(2022) Page Start: 216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Secondary Complete Cytoreduction in Recurrent Ovarian Cancer: Benefit of Optimal Patient Selection Using Scoring System. Issue 2 (1st February 2014) Authors: Laas, Enora; Luyckx, Mathieu; De Cuypere, Marjolein; Selle, Frederic; Daraï, Emile; Querleu, Denis; Rouzier, Roman; Chéreau, Elisabeth Journal: International journal of gynecological cancer Issue: Volume 24:Issue 2(2014) Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗